Role of ALBI Grade as a Predictive Factor for Long‐Term Mortality in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1111/jgh.70098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Kyoung A Ko und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Kor…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic, Bilirubin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Background
This study investigated the role of the albumin–bilirubin (ALBI) grade as a predictive factor for mortality in patients with favorable liver function undergoing transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC).
Methods
A total of 251 HCC patients with Child–Pugh class A and a model for end‐stage liver disease (MELD) score < 10 who received TACE as initial treatment were analyzed. Predictive factors for overall survival were assessed.
Results
The mean age was 61.5 years, and the median follow‐up was 10.3 years. A high ALBI grade (ALBI score > −2.60) was observed in 147 patients (59%). Multivariable analysis showed that mortality was significantly associated with Barcelona Clinic Liver Cancer (BCLC) stage B (hazard ratio [HR] 2.21, 95% confidence interval [CI] 1.24–3.93, p = 0.007), BCLC stage C (HR 4.80, 95% CI 2.76–8.34, p < 0.001), presence of ascites (HR 2.28, 95% CI 1.31–3.97, p = 0.003), progressive disease (PD) of tumor response (HR 2.95, 95% CI 1.76–4.93, p < 0.001), and high ALBI grade (Grade ≥ 2) (HR 1.96, 95% CI 1.20–3.21, p = 0.008). Overall survival differed significantly by ALBI grade: the 3‐, 6‐, 9‐, and 12‐year survival rates were 80.4%, 78.7%, 76.2%, and 65.5% in the low ALBI group (Grade 1) and 61.3%, 42.8%, 35.7%, and 35.7% in the high ALBI group (Grade ≥ 2) ( p < 0.001).
Conclusions
High ALBI grade (Grade ≥ 2) is associated with increased mortality in patients with Child–Pugh class A and low MELD score undergoing TACE for HCC. ALBI grade may serve as a predictor of survival in patients with preserved liver function receiving TACE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Department of Radiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
ORCID-Profile: Kyoung A Ko, Won Sohn
Zitieren
APA
Ko, K. A., Oh, H., Kim, M. S., Hong, H. P., Cho, Y. K., Kim, B. I., & Sohn, W. (2025). Role of ALBI Grade as a Predictive Factor for Long‐Term Mortality in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70098
Vancouver
Ko KA, Oh H, Kim MS, Hong HP, Cho YK, Kim BI, et al. Role of ALBI Grade as a Predictive Factor for Long‐Term Mortality in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.70098
BibTeX
@article{Ko2025,
author = {Ko, Kyoung A and Oh, Hyunwoo and Kim, Myung Sub and Hong, Hyun Pyo and Cho, Yong Kyun and Kim, Byung Ik and Sohn, Won},
title = {Role of ALBI Grade as a Predictive Factor for Long‐Term Mortality in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1111/jgh.70098}
}
EUVIMED